Catalyst Wire Dossier Catalyst Wire Dossier

CSL787

· CSL Behring
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CSL787, covering 2025-11-10 to 2025-11-10. Get the full timeline:

Most recent: Clinical Trial Update: Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With Non-cystic Fibrosis Bronchiectasis (NCFB) [Phase 2]

See pricing